Retatrutide Research Peptide | Biovantage Labs

Retatrutide Research Peptide | Biovantage Labs

Retatrutide is a tri-agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously, studied for its multi-axis effects on energy homeostasis, adipose tissue regulation, and insulin secretion research models. Biovantage Labs supplies Retatrutide at 99+% purity, HPLC/MS verified. Domestically fulfilled from Canada. Not for human consumption.

$100.00

Description

Retatrutide – Biovantage Labs Research Peptide

Retatrutide is a tri-agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously, studied for its multi-axis effects on energy homeostasis, adipose tissue regulation, and insulin secretion research models. Biovantage Labs supplies Retatrutide at 99+% purity, HPLC/MS verified. Domestically fulfilled from Canada. Not for human consumption. Biovantage Labs provides this compound at 99+% purity, confirmed by batch-specific HPLC and Mass Spectrometry analysis, as a lyophilized compound for use in controlled laboratory settings.

Molecular Profile and Chemical Specifications

Specification Detail
Molecular Formula C222H348N48O68
Molecular Weight 4,759.5 Da
Classification GLP-1 / GIP / Glucagon receptor tri-agonist
Purity ≥99+% (HPLC/MS verified)
Physical Form Lyophilized white powder
CAS Number 2381089-83-2

 

Primary Research Mechanisms

Triple Incretin Receptor Co-Activation

Retatrutide simultaneously activates three receptors GLP-1R, GIPR, and GcgR creating a multi-pathway metabolic signalling profile. Research using Retatrutide examines how concurrent activation of these axes compares to single or dual-agonist approaches in metabolic research models.

Research using Retatrutide as a tri-agonist tool is often designed with Semaglutide as a GLP-1-selective reference compound, allowing investigators to attribute specific metabolic outcomes to GIP and glucagon receptor co-activation by comparing results across the two research tools.

Glucagon Receptor Activation and Energy Expenditure

The glucagon receptor component of Retatrutide’s profile is studied for its effects on hepatic glucose production and thermogenesis. Research examines whether glucagon co-activation counterbalances or complements the insulinotropic effects of GLP-1R and GIPR co-stimulation.

GIP Receptor Contributions to Adipose Regulation

GIPR signalling is studied in adipocyte research for its role in lipid storage and release. The inclusion of GIPR agonism in Retatrutide’s profile distinguishes it from GLP-1-only agonists and allows for comparative research into GIP-specific contributions to metabolic regulation.

For research examining alternative tri-agonist profiles, Trizeptide replaces glucagon receptor agonism with FGF21R agonism within a similar GLP-1/GIP framework, enabling comparative investigation of the distinct metabolic contributions of glucagon versus FGF21 receptor co-activation.

Reconstitution Protocol

  •       Reconstitute using sterile bacteriostatic water or 0.9% sodium chloride solution
  •       Introduce diluent slowly along the interior vial wall do not inject directly onto the lyophilized cake
  •       Swirl gently until fully dissolved do not shake or vortex
  •       Allow the vial to equilibrate to room temperature before opening to prevent condensation

Storage and Stability

Storage Condition State Estimated Stability
-20°C to -80°C Lyophilized 24+ months
2°C to 8°C Lyophilized 12 months
Room temperature (20°C) Lyophilized 3 months
2°C to 8°C Reconstituted 7 to 14 days

 

Store in a desiccated environment away from UV exposure. Avoid repeated freeze-thaw cycles, which degrade peptide chain integrity over time.

Retatrutide Research FAQ

Q: What makes Retatrutide a tri-agonist rather than a dual agonist?

A: Retatrutide was designed to engage three distinct G-protein coupled receptors GLP-1R, GIPR, and the glucagon receptor within a single peptide scaffold. This distinguishes it from dual agonists such as tirzepatide (GLP-1/GIP only) and allows research to investigate the additional metabolic contributions of glucagon receptor co-activation.

Q: Is Retatrutide for human use?

A: No. Retatrutide supplied by Biovantage Labs is strictly for laboratory research purposes. It is not approved for human consumption, veterinary use, or clinical application.

Q: What purity standard does Biovantage Labs apply?

A: Every batch is verified at 99+% purity using HPLC to confirm compound concentration and Mass Spectrometry to confirm molecular identity. Batch-specific COA documentation is available upon request.

Q: Where does Biovantage Labs ship from?

A: All Biovantage Labs products are fulfilled domestically from within Canada, eliminating customs clearance risk and reducing transit time compared to international suppliers.

Reviews

There are no reviews yet.

Be the first to review “Retatrutide Research Peptide | Biovantage Labs”

Your email address will not be published. Required fields are marked *

Related Products

High Quality Research Peptides You Can Trust

Explore premium-grade peptides for scientific research, purity tested, lab certified, and shipped discreetly.